Shenzhen YHLO Biotech Co., Ltd. (688575.SS) SHH

Currency In CNY

AD

Valuation

Market Cap8.53B
Enterprise Value8.99B
P/E Ratio75.99
PEG Ratio-1.42
Price/Sales Ratio3.03
Price/Book Ratio2.08
Enterprise/Revenue3.19
Enterprise/EBITDA14.73

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue1.81B
Revenue/Share3.31
Gross Profit1.81B
EBITDA481.96M
Net Income23.34M
Diluted EPS0.04

Balance Sheet

Total Cash705.67M
Total Cash/Share1.24
Total Debt1.01B
Total Debt/Equity0.37
Current Ratio2.14
Book Value Per Share4.8

Price History

52-Week Change-31.22
52-Week High17
52-Week Low8.34
Moving Average 50 Days10.09
Moving Average 200 Days11.78

Statistics

Average Volume11M
Shares Outstanding571.42M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.02
Trailing Annual Dividend Yield0.21
Payout Ratio0.45
Last Split Factor7:5
Last Split DateJune 02, 2022
AD